Imaging Dynamics Company Ltd. (IDYLF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Imaging Dynamics Company Ltd. (IDYLF) trades at $0.0235 with AI Score 48/100 (Grade C). Imaging Dynamics Company Ltd. Sector: Healthcare.
Price as of Jul 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for IDYLF: IDYLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IDYLF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IDYLF: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Imaging Dynamics Company Ltd. (IDYLF) Healthcare & Pipeline Overview
Imaging Dynamics Company Ltd. is a Canadian medical technology firm specializing in digital radiography solutions for human and veterinary applications. It offers imaging detectors, proprietary software like Magellan and Sirius, and integrated DR systems, distributing globally through a network of dealers, distributors, and OEM partners, positioning itself in a dynamic healthcare imaging market.
What Is the Investment Thesis for IDYLF?
Imaging Dynamics Company Ltd. operates within the growing digital radiography market, offering a diversified product portfolio that includes advanced imaging detectors, proprietary software, and integrated DR systems for both human and veterinary applications. The company's global distribution network, leveraging independent dealers, value-added distributors, and OEM partners, provides a foundation for market penetration. Key value drivers include the ongoing transition from analog to digital imaging technologies in healthcare, which creates sustained demand for its core products, and the increasing adoption of advanced diagnostics in the veterinary sector, where its VetnovaXion detectors and Sirius software are specifically positioned. However, the company faces significant financial challenges, evidenced by a profit margin of -962.6% and a market capitalization of $0.00B, indicating substantial unprofitability and a very small operational scale. Its gross margin of 38.6% suggests some efficiency in core operations, but overall profitability remains a major concern. The stock's Beta of 1.79 indicates higher volatility compared to the broader market. The company's OTC Other tier listing also presents challenges related to liquidity and disclosure, which investors must consider.
Based on FMP financials and quantitative analysis
IDYLF Key Highlights
- The company reported a significant negative profit margin of -962.6%, indicating substantial unprofitability in its operations.
- Imaging Dynamics maintains a gross margin of 38.6%, suggesting a reasonable margin on its core product sales before operating expenses.
- With a market capitalization of $0.00B, the company is categorized as a micro-cap entity, reflecting its very small scale.
- The stock exhibits a Beta of 1.79, indicating higher volatility and sensitivity to market movements compared to the overall market.
- Imaging Dynamics Company Ltd. employs 89 individuals, reflecting its operational size as a specialized medical technology firm.
Who Are IDYLF's Competitors?
IDYLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNVIF Conavi Medical Corp. | $0.15 | -5.64% | $12.9M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.08 | -2.68% | $15.0M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.22 | +0.04% | $20.9M | 73 |
| PLSM PLSM | $3.56 | +1.42% | $23.2M | 60 |
| NVYTF Novacyt S.A. | $0.48 | -0.00% | $34.8M | 61 |
| DNAY Codex DNA, Inc. | $1.30 | +8.33% | $38.3M | 68 |
| NVCN Neovasc Inc. | $30.03 | +0.00% | $82.9M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IDYLF's Key Strengths?
- Diverse product portfolio covering both human and veterinary digital radiography solutions.
- Proprietary image processing software (Magellan, Sirius) enhances diagnostic capabilities.
- Established global distribution network through dealers, distributors, and OEM partners.
- Offers complete integrated DR systems, simplifying procurement for customers.
What Are IDYLF's Weaknesses?
- Significant unprofitability with a reported profit margin of -962.6%.
- Very small market capitalization ($0.00B) indicates limited financial resources and scale.
- OTC Other tier listing may result in lower liquidity and less transparent disclosure.
- Reliance on a distribution network means less direct control over sales and customer relationships.
What Could Drive IDYLF Stock Higher?
- Potential for new product launches or significant upgrades to existing digital radiography detectors or software platforms, which could drive increased sales and market share.
- Expansion of the company's distribution network through new partnerships with independent dealers, value-added distributors, or OEM partners, enhancing global market reach.
- Increased adoption of digital radiography technology in emerging markets, where healthcare infrastructure is evolving, potentially leading to higher demand for IDYLF's solutions.
- Strategic initiatives to improve operational efficiency and address the significant negative profit margin, which could signal a path towards profitability.
- Growth in the veterinary imaging market, driven by increased pet ownership and demand for advanced animal healthcare, leveraging IDYLF's specialized VetnovaXion and Sirius products.
What Are the Key Risks for IDYLF?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial instability, as evidenced by a profit margin of -962.6% and a market capitalization of $0.00B, posing a substantial risk to long-term viability.
- Intense competition within the medical devices industry from larger, well-capitalized companies that may have superior R&D capabilities and market presence.
- Regulatory hurdles and compliance costs associated with medical devices, which can be complex and expensive, potentially delaying product commercialization or increasing operational expenses.
- Dependence on a network of third-party dealers, distributors, and OEM partners for sales and market penetration, which could lead to variable sales performance and reduced control over market strategy.
- Challenges related to its OTC Other tier listing, including limited liquidity, potential for price manipulation, and lack of comprehensive public disclosure, increasing investment risk.
What Are the Growth Opportunities for IDYLF?
- Growth opportunity 1: Expanding market penetration in emerging economies and underserved regions within the Americas and internationally. As healthcare infrastructure develops in these areas, there is an increasing demand for cost-effective and efficient digital imaging solutions. Imaging Dynamics' established global distribution network, comprising independent dealers and value-added distributors, provides a foundational platform to capitalize on this trend by strategically targeting new clinics, hospitals, and veterinary practices seeking to upgrade their imaging capabilities from analog to digital systems. This geographic expansion could unlock new revenue streams and diversify its customer base.
- Growth opportunity 2: Capitalizing on the robust growth within the global veterinary imaging market. The increasing humanization of pets, coupled with advancements in animal healthcare, is driving higher demand for sophisticated diagnostic tools, including digital radiography. Imaging Dynamics is well-positioned with its VetnovaXion flat panel detectors and Sirius veterinary image processing software, which are specifically designed for animal applications. Expanding marketing efforts and product offerings tailored to veterinary clinics and animal hospitals could significantly increase sales in this specialized, high-growth segment, leveraging its existing product differentiation.
- Growth opportunity 3: Continuous innovation and technological upgrades in its flat panel detector and software offerings. The medical imaging sector is characterized by rapid technological advancements. By investing in research and development to enhance image resolution, reduce dose, improve processing speed, and integrate AI-powered diagnostic features into its Aquarius 8600 and Magellan software, Imaging Dynamics can maintain a competitive edge. These advancements would attract new customers seeking cutting-edge solutions and encourage existing clients to upgrade their equipment, ensuring the company remains relevant in a fast-evolving market.
- Growth opportunity 4: Strengthening and expanding its original equipment manufacturer (OEM) partnerships. Collaborating with other medical device manufacturers allows Imaging Dynamics to integrate its core components, such as flat panel detectors, into broader imaging systems or other medical equipment produced by larger companies. This strategy enables the company to significantly broaden its market reach and sales volume without incurring the full costs associated with direct sales and marketing for complete systems. Cultivating new OEM relationships and deepening existing ones can provide a stable revenue stream and validate the quality of its core technologies.
- Growth opportunity 5: Promoting the adoption of its integrated digital radiography systems, such as the 1600 Plus X-Series, as comprehensive solutions. By emphasizing the benefits of a fully integrated system that includes the X-ray tube, collimator, generator, and multi-axis positioning device, Imaging Dynamics can appeal to healthcare providers looking for streamlined procurement and seamless operational efficiency. This approach allows the company to capture a larger share of the overall imaging equipment budget per client, moving beyond component sales to offering complete, high-value diagnostic suites for both human and veterinary applications.
What Opportunities Does IDYLF Have?
- Growing global demand for digital radiography solutions as healthcare facilities upgrade from analog systems.
- Expansion of the veterinary imaging market driven by increased pet care spending and technological adoption.
- Potential for technological advancements in flat panel detectors and AI-powered software to enhance product offerings.
- Deepening and expanding OEM partnerships to broaden market reach without significant capital expenditure.
What Threats Does IDYLF Face?
- Intense competition from larger, more established medical imaging companies with greater R&D budgets.
- Rapid technological obsolescence requiring continuous investment in product development.
- Stringent regulatory approval processes for medical devices, potentially delaying product launches.
- Economic downturns or healthcare spending cuts could reduce demand for new imaging equipment.
What Are IDYLF's Competitive Advantages?
- Proprietary image processing software (Magellan for human, Sirius for veterinary) offers specialized diagnostic capabilities.
- Comprehensive product portfolio spanning detectors, software, and integrated DR systems for both human and veterinary markets.
- Established global distribution network through dealers, distributors, and OEM partners provides market access.
- Specific product branding (Aquarius 8600, VetnovaXion, 1600 Plus X-Series) builds recognition in niche segments.
- Integrated DR systems like the 1600 Plus X-Series offer a complete solution, potentially reducing complexity for purchasers.
What Does IDYLF Do?
Imaging Dynamics Company Ltd. operates as a specialized medical technology firm, providing advanced digital radiography (DR) solutions across the Americas and on a global scale. Established in 1995 as Imaging Dynamics Corporation, the company evolved its identity to Imaging Dynamics Company Ltd. in October 2001, solidifying its commitment to the medical imaging sector. Headquartered in Toronto, Canada, the company has developed a comprehensive product portfolio designed to meet the diverse needs of both human medical diagnostics and veterinary care. At the core of its offerings are state-of-the-art imaging detectors, including flat panel models such as the Aquarius 8600, specifically engineered for medical applications, and the VetnovaXion, tailored for veterinary use. Beyond hardware, Imaging Dynamics distinguishes itself through its proprietary image processing software. Magellan software is developed for human medical diagnostics, providing clinicians with tools for precise image analysis, while Sirius software caters to veterinary imaging, enhancing diagnostic capabilities for animal healthcare professionals. This dual focus on human and animal health allows the company to address a broader market segment within the medical technology landscape. Furthermore, the company delivers complete digital radiography (DR) systems. A notable example is the 1600 Plus X-Series, an integrated solution that features a floor-mounted U-arm multi-axis positioning device, meticulously combined with an X-ray tube, collimator, and generator to form a cohesive imaging unit. Complementing its human medical systems, Imaging Dynamics also offers specialized DR systems for veterinary practices. The distribution strategy relies on a robust and extensive network comprising independent dealers, value-added distributors, and original equipment manufacturer (OEM) partners, ensuring broad market reach and efficient product delivery to its global customer base.
What Products and Services Does IDYLF Offer?
- Develops and supplies digital radiography (DR) solutions for medical and veterinary applications.
- Offers flat panel imaging detectors, including Aquarius 8600 for human medical use and VetnovaXion for veterinary use.
- Creates specialized image processing software: Magellan for human medical diagnostics.
- Develops Sirius, a dedicated image processing software for veterinary imaging.
- Provides comprehensive digital radiography (DR) systems, such as the 1600 Plus X-Series.
- The 1600 Plus X-Series includes a floor-mounted U-arm multi-axis positioning device, X-ray tube, collimator, and generator.
- Offers specific DR systems tailored for veterinary practices.
- Distributes products globally through independent dealers, value-added distributors, and OEM partners.
How Does IDYLF Make Money?
- Generates revenue through the sale of digital radiography (DR) hardware, including imaging detectors and complete DR systems.
- Sells specialized image processing software (Magellan and Sirius) as part of its integrated solutions.
- Utilizes a multi-channel distribution strategy, partnering with independent dealers and value-added distributors for market reach.
- Engages with Original Equipment Manufacturer (OEM) partners to integrate its components into broader systems, expanding sales.
- Focuses on both human medical diagnostics and veterinary imaging markets, diversifying its customer base and product applications.
What Industry Does IDYLF Operate In?
Imaging Dynamics Company Ltd. operates within the dynamic and technologically evolving Medical Devices industry, specifically focusing on digital radiography solutions. This sector is characterized by a global shift from traditional analog X-ray systems to advanced digital imaging technologies, driven by benefits such as enhanced image quality, reduced radiation exposure, faster processing times, and improved workflow efficiency. The competitive landscape includes large, established medical imaging conglomerates as well as specialized digital radiography providers. Imaging Dynamics positions itself by offering a comprehensive suite of products, including flat panel detectors, proprietary image processing software (Magellan for human, Sirius for veterinary), and integrated DR systems, catering to both human medical diagnostics and the growing veterinary market. While the broader medical imaging market continues to expand due to an aging global population and increasing prevalence of chronic diseases, the company's success hinges on its ability to innovate, secure regulatory approvals, and effectively compete against larger players with greater R&D and marketing resources.
Who Are IDYLF's Key Customers?
- Hospitals and medical clinics requiring digital radiography equipment for human diagnostics.
- Veterinary clinics and animal hospitals seeking advanced imaging solutions for animal care.
- Independent dealers who resell medical and veterinary technology products.
- Value-added distributors who integrate and distribute specialized medical equipment.
- Original Equipment Manufacturers (OEMs) who incorporate IDYLF's components into their own systems.
Imaging Dynamics Company Ltd. (IDYLF) Valuation Context
Relative to its peer group, IDYLF's quantitative score of 48/100 is below the peer average of 65/100.
ROE 12%Key Financial Metrics
Return on equity for Imaging Dynamics Company Ltd. stands at 11.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -193.4%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Imaging Dynamics Company Ltd.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
IDYLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio covering both human and veterinary digital radiography solutions.
- Proprietary image processing software (Magellan, Sirius) enhances diagnostic capabilities.
- Established global distribution network through dealers, distributors, and OEM partners.
- Offers complete integrated DR systems, simplifying procurement for customers.
Bear Case
- Significant unprofitability with a reported profit margin of -962.6%.
- Very small market capitalization ($0.00B) indicates limited financial resources and scale.
- OTC Other tier listing may result in lower liquidity and less transparent disclosure.
- Reliance on a distribution network means less direct control over sales and customer relationships.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IDYLF Latest News
-
Stocks That Hit 52-Week Lows On Wednesday
· Jan 29, 2020
IDYLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IDYLF.
Price Targets
Wall Street price target analysis for IDYLF.
IDYLF MoonshotScore
What does this score mean?
The MoonshotScore rates IDYLF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Yong Yan
CEO
The specific career history, educational background, and previous roles for Yong Yan are not provided in the available source data. It is known that Yong Yan is responsible for managing the company's 89 employees, overseeing the strategic direction and operational execution of Imaging Dynamics Company Ltd. within the medical technology sector. Further details regarding their professional journey prior to this role are unknown.
Track Record: Specific key achievements, strategic decisions, or company milestones directly attributable to Yong Yan's leadership are not detailed in the provided information. The available data indicates that Yong Yan is at the helm of Imaging Dynamics Company Ltd., guiding its operations in the digital radiography market. Any specific track record regarding financial performance or product development under their tenure is unknown.
IDYLF OTC Market Information
Imaging Dynamics Company Ltd. trades on the OTC Other tier, which is the lowest of the three primary OTC Markets tiers (OTCQX, OTCQB, and OTC Pink). The 'OTC Other' designation typically applies to companies that do not meet the minimum disclosure requirements for OTCQB or OTCQX, or that are in financial distress, bankruptcy, or have not provided current information to OTC Markets. Unlike exchanges like the NYSE or NASDAQ, which have strict listing standards for financials, governance, and disclosure, OTC Other has minimal to no requirements, leading to significantly less transparency and investor protection. This tier is often associated with penny stocks and can be highly speculative.
- OTC Tier: OTC Other
- Limited Transparency: Unknown disclosure status means investors lack access to critical financial and operational information, making informed decisions difficult.
- Low Liquidity: Trading on the OTC Other tier with a negligible market cap likely results in very low trading volume and wide bid-ask spreads, hindering efficient trading.
- Price Volatility: OTC stocks, especially those in lower tiers, are often subject to extreme price volatility due to low trading volume and speculative interest.
- Fraud Risk: The lack of stringent regulatory oversight and disclosure requirements on the OTC Other tier can expose investors to a higher risk of fraud or manipulation.
- Difficulty in Valuation: Without consistent and transparent financial reporting, accurately valuing the company's assets, liabilities, and future prospects becomes highly speculative.
- Verify the company's current financial statements and audit reports, if any are available, despite the 'Unknown' disclosure status.
- Research any news, press releases, or corporate filings that might be available through third-party sources or provincial regulators in Canada.
- Assess the company's operational status, product pipeline, and distribution network through independent research, as official disclosures may be limited.
- Investigate any legal or regulatory actions against the company or its management.
- Understand the market for digital radiography and the company's competitive position without relying solely on internal company statements.
- Evaluate the management team's experience and track record, seeking information beyond what is publicly disclosed.
- Consider the potential for dilution from future capital raises, which are common for small, unprofitable companies.
- The company has a clear business description, operating as a medical technology firm with specific products (detectors, software, DR systems).
- It has a defined product portfolio for both human and veterinary applications, indicating a structured business model.
- The company has an established founding history (1995) and a corporate headquarters in Toronto, Canada.
- It utilizes a robust distribution network including independent dealers, value-added distributors, and OEM partners, suggesting operational activity.
- The company has a known CEO, Yong Yan, indicating active management.
Common Questions About IDYLF (Healthcare)
What does the AI Score mean for IDYLF?
IDYLF holds an AI Score of 48/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Imaging Dynamics Company Ltd. is a medical technology firm that provides digital radiography solutions globally, encompassing imaging detectors, proprietary software, and integrated DR systems …
What does Imaging Dynamics Company Ltd. do?
Imaging Dynamics Company Ltd. is a medical technology company specializing in digital radiography (DR) solutions for both human medical diagnostics and veterinary applications. The company's core offerings include advanced flat panel imaging detectors, such as the Aquarius 8600 for medical use and VetnovaXion for veterinary purposes.
How does Imaging Dynamics Company Ltd. navigate regulatory approval processes for its medical devices?
The provided source data does not offer specific details regarding Imaging Dynamics Company Ltd.'s track record or strategy for navigating regulatory approval processes, such as those from the FDA or EMA. Operating in the medical devices industry, the company's products, including its imaging detectors and DR systems, would typically be subject to rigorous regulatory scrutiny to ensure safety and efficacy.
What are the key challenges and risks for IDYLF operating in the medical technology sector?
Imaging Dynamics Company Ltd. faces several significant challenges and risks within the medical technology sector. Financially, the company exhibits substantial unprofitability, indicated by a profit margin of -962.6%, and operates with a very small market capitalization of $0.00B, suggesting limited financial resources for R&D and market expansion.
What are the key factors to evaluate for IDYLF?
Imaging Dynamics Company Ltd. (IDYLF) holds an AI score of 48/100 (low). Not financial advice.
How frequently does IDYLF data refresh on this page?
IDYLF's price was last updated on Jul 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven IDYLF's recent stock price performance?
Imaging Dynamics Company Ltd. (IDYLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio covering both human and veterinary digital radiography solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IDYLF overvalued or undervalued right now?
Imaging Dynamics Company Ltd. (IDYLF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research IDYLF before investing?
Before investing in Imaging Dynamics Company Ltd. (IDYLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Specific market size data and CAGR for growth opportunities were not provided in the source and thus could not be included, adhering to the 'no speculation' rule.
- Detailed CEO background, track record, and specific title beyond 'CEO' were not provided in the source.
- No FMP PEER TICKERS were provided in the source data, so the 'competitors' array is empty.
- The disclosure status for OTC is 'Unknown', which limits the detail that can be provided on financial reports.
- Specific regulatory track record or strategy details were not provided in the source for the FAQ.